Trial Details

COMPLETED
Basic Information
Clinical ID c1204
Identifier NCT03648541
Trial Title BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Colitis, Ulcerative
Interventions DRUG: Spesolimab
Participant Information
Sponsor Boehringer Ingelheim
City Hamden
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2018-10-29
Primary Completion Date 2023-05-03
Completion Date 2023-05-03